How is imatinib mesylate given (administered)?
Imatinib mesylate is administered orally, in the form of a capsule, and the dose depends on several factors, including the condition being treated, the size of the patient, the particular regimen being used, and the overall health of the patient. It should be taken with food and a large glass of water to minimize gastrointestinal irritation.How are patients monitored? Patients will usually have scheduled meetings with their healthcare provider while they are being treated with imatinib mesylate. Typically, blood will be drawn to check levels of blood cells and to monitor functions of some organ systems, such as the kidneys or liver. Patients may also undergo physical examinations, scans or other measures to assess side effects and response to therapy.What are the common (occur in 30% or more of patients) side effects of treatment with imatinib mesylate?• Low white blood cell levels – increases risk of infection • Low red blood cell levels – increases risk of anemia • Low platelet level
